Teva Pharma (NYSE: TEVA) October weekly call option implied volatility is at 70 from 40, October is at 56 from 41, November is at 57; compared to its 52-week range of 24 to 61 on Mylan (Nasdaq; MYL) was granted FDA approval of the first generic for Copaxone.